Comment Re:Everything we eat is GM. Everything. (Score 1) 427
Sorry for the delay between posts, but I only get to check /. infrequently these days.
Lappe and Baily are not technically wrong because they qualified their argument with 'could', not 'will'.
The canonical basis for their argument is something like the Flavr Savr tomato. What happened in that case was a biotech company with no traditional plant breeding experience employed a very early and expensive GM transformation process to a single variety of tomato (which, incidentally, happened to suck). Because of the development expenses and lack of understanding of the market, they only developed that one variety, hence a lack of genetic diversity of flavr savr tomatoes.
Taking a step back to explain, I'll start with the fact that all transgenes on the market in field crops today do not actually impact the quality of the product to the consumer at all. They don't make them taste better, look better, more nutritious, etc. This is actually largely due to regulatory reasons, as the FDA has much more stringent testing requirements if a product is actually supposed to impact the consumer as opposed to lighter restrictions if you can prove that there is no interaction intended or in practice (e.g., BT transgenic crops produce a protein that does not interact with animal digestive systems at all (and that organic farmers actually spray on their crops, incidentally)). All current field crop transgenes make the production process cheaper, more energy efficient, etc.
Anyway, in effect, transgenes basically add on a feature to an existing variety, leaving all other traits of that variety unmodified. If you added the round-up ready transgene to the red delicious apple variety, they would taste exactly like normal red delicious apples. As far as the consumer was concerned, there would be no discernable difference (unless you had a genetic or protein analysis lab at your disposal).
If you're a developer of apple varieties, and you wanted to offer your full lineup with transgenics, you would have to add the genes to every single variety of apple separately.
Development of varieties of a crop, and development and integration of transgenes into a crop, are basically two separate processes.
Due to current technological limitations, market pressures, regulatory requirements, and other business factors, transgenes are used for single-gene qualitative traits (e.g., herbicide/insect resistance) rather than quantitative ones (e.g., yield).
As if this post weren't long enough, let me use a car analogy:
Traditional breeding is like developing new cars. You use better manufacturing techniques, materials, and refined aesthetic focus to improve model lines or even come out with new line altogether.
Transgenics are like developing accessories that will fit a wide variety of vehicles, such as stereos, A/C systems, power steering, etc.
The Flavr Savr guys made the mistake of thinking that their transgene would singlehandedly ensure success despite the fact that they used a crap variety as the base of their product. It was comparable to OnStar thinking their system is so awesome that they could throw it into a Pinto and it'd sell like hotcakes even though it would be competing with similarly priced BMWs.
Lappe and Baily's argument is essentially based on the premise that all companies offering transgenes will ignore Calgene's mistake and repeat it blindly. Companies have done many stupid things, so this is not entirely unthinkable, but it is hardly likely and has not happened in practice.
Compared to transgenics, the advent of hybrids and commercial production farming have caused a decline in genetic diversity to a much larger extent. They have also caused orders of magnitude greater production, without which we would have been suffering global famine since the 60s, so it is something to weigh against the potential risks: narrowing the genetic diversity of production field crops is actually preventing global famine right now, but could also potentially contribute to widespread crop failure in the future.
Lappe and Baily are not technically wrong because they qualified their argument with 'could', not 'will'.
The canonical basis for their argument is something like the Flavr Savr tomato. What happened in that case was a biotech company with no traditional plant breeding experience employed a very early and expensive GM transformation process to a single variety of tomato (which, incidentally, happened to suck). Because of the development expenses and lack of understanding of the market, they only developed that one variety, hence a lack of genetic diversity of flavr savr tomatoes.
Taking a step back to explain, I'll start with the fact that all transgenes on the market in field crops today do not actually impact the quality of the product to the consumer at all. They don't make them taste better, look better, more nutritious, etc. This is actually largely due to regulatory reasons, as the FDA has much more stringent testing requirements if a product is actually supposed to impact the consumer as opposed to lighter restrictions if you can prove that there is no interaction intended or in practice (e.g., BT transgenic crops produce a protein that does not interact with animal digestive systems at all (and that organic farmers actually spray on their crops, incidentally)). All current field crop transgenes make the production process cheaper, more energy efficient, etc.
Anyway, in effect, transgenes basically add on a feature to an existing variety, leaving all other traits of that variety unmodified. If you added the round-up ready transgene to the red delicious apple variety, they would taste exactly like normal red delicious apples. As far as the consumer was concerned, there would be no discernable difference (unless you had a genetic or protein analysis lab at your disposal).
If you're a developer of apple varieties, and you wanted to offer your full lineup with transgenics, you would have to add the genes to every single variety of apple separately.
Development of varieties of a crop, and development and integration of transgenes into a crop, are basically two separate processes.
Due to current technological limitations, market pressures, regulatory requirements, and other business factors, transgenes are used for single-gene qualitative traits (e.g., herbicide/insect resistance) rather than quantitative ones (e.g., yield).
As if this post weren't long enough, let me use a car analogy:
Traditional breeding is like developing new cars. You use better manufacturing techniques, materials, and refined aesthetic focus to improve model lines or even come out with new line altogether.
Transgenics are like developing accessories that will fit a wide variety of vehicles, such as stereos, A/C systems, power steering, etc.
The Flavr Savr guys made the mistake of thinking that their transgene would singlehandedly ensure success despite the fact that they used a crap variety as the base of their product. It was comparable to OnStar thinking their system is so awesome that they could throw it into a Pinto and it'd sell like hotcakes even though it would be competing with similarly priced BMWs.
Lappe and Baily's argument is essentially based on the premise that all companies offering transgenes will ignore Calgene's mistake and repeat it blindly. Companies have done many stupid things, so this is not entirely unthinkable, but it is hardly likely and has not happened in practice.
Compared to transgenics, the advent of hybrids and commercial production farming have caused a decline in genetic diversity to a much larger extent. They have also caused orders of magnitude greater production, without which we would have been suffering global famine since the 60s, so it is something to weigh against the potential risks: narrowing the genetic diversity of production field crops is actually preventing global famine right now, but could also potentially contribute to widespread crop failure in the future.